The company has not filed an annual or quarterly report since its Q3 FY2022 10-Q, filed Nov 22, 2022. Its latest SEC filing is a SC 13G/A from Feb 14, 2023.
10-Q for Q3 FY2022, filed Nov 22, 2022
The sections below describe the company as of the FY2021 annual report.
Seeks to combine with a business, with a focus on potential targets in the biopharmaceutical sector.
10-K for FY2021, filed Apr 15, 2022
No revenue was reported.
10-K for FY2021, filed Apr 15, 2022
10-Q for Q3 FY2022, filed Nov 22, 2022
−$185.8KView ↗
8-K, filed Nov 18, 2022
Palo Alto, CA – November 18, 2022 – Jiya Acquisition Corp. (the “Company”) today announced that it will redeem all of its outstanding Class…View ↗
Loading...